CHANTIX Trademark

Trademark Overview

On Wednesday, March 25, 2020, a trademark application was filed for CHANTIX with the United States Patent and Trademark Office. The USPTO has given the CHANTIX trademark a serial number of 88847449. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2022. This trademark is owned by Pfizer Inc.. The CHANTIX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, smoking cessation preparations
chantix

General Information

Serial Number88847449
Word MarkCHANTIX
Filing DateWednesday, March 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Description of MarkThe mark consists of the stylized word "CHANTIX" with the top half of the "X" formed by a check mark.
Goods and Servicespharmaceutical preparations, namely, smoking cessation preparations
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, September 26, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 4, 2022SOU EXTENSION 3 GRANTED
Tuesday, January 4, 2022SOU EXTENSION 3 FILED
Tuesday, January 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 25, 2021SOU EXTENSION 2 GRANTED
Friday, June 25, 2021SOU EXTENSION 2 FILED
Friday, June 25, 2021SOU TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 1 GRANTED
Thursday, December 3, 2020SOU EXTENSION 1 FILED
Thursday, December 3, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2020ASSIGNED TO LIE
Monday, May 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 18, 2020EXAMINER'S AMENDMENT ENTERED
Monday, May 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 18, 2020EXAMINERS AMENDMENT E-MAILED
Monday, May 18, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, May 14, 2020ASSIGNED TO EXAMINER
Tuesday, March 31, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, March 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 28, 2020NEW APPLICATION ENTERED

Related Keywords

chantix preparations cessation smoking namely pharmaceutical